ReviewBasic and clinical neuroscience2025
Pathways Mediating Blindsight After V1 Injury: A Systematic Review of Human and Monkey Studies.
Review in Basic and clinical neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Although damage to the visual area (V1) leads to visual impairment, some patients retain the ability to process visual information unconsciously, a phenomenon known as blindsight. This study aims to systematically review and compare the proposed neural pathways mediating blindsight in humans and monkeys, providing a structured framework for future investigations in this field. Methods: This is a systematic review of related articles retrieved from online databases. Following the screening process, we employed the JBI critical appraisal checklist as well as the SYRCLE tool to assess the risk of bias in human and animal studies. We selected 25 articles focusing on the mediating pathways of blindsight. Results: In humans, the pathways from the lateral geniculate nucleus (LGN) to V5, from the superior colliculus (SC) to higher brain areas, and to the remaining segments of V1 are crucial. The pathway that connects the SC, pulvinar, and amygdala is essential for processing emotional visual information. Studies conducted on monkeys emphasized the importance of the SC-pulvinar pathway and the connections between the LGN and extrastriate visual areas for developing blindsight. Conclusion: Rather than a single consistent pathway, blindsight appears to involve multiple parallel routes whose engagement depends on factors such as lesion extent, individual neuroanatomy, and time since injury. Future studies should explore the therapeutic potential of these pathways by integrating.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.